Introduction
============

Sepsis is a significant public health concern, accounting for approximately 10% of total U.S. deaths annually (Angus et al., [@B12]; Martin et al., [@B49]; Vincent et al., [@B81]; Heron et al., [@B42]). For most infections, despite antibiotic treatments, death occurs primarily through the final common pathway of sepsis-induced multiple organ dysfunction syndrome (MODS).As the population ages, the preponderance of complex medical co-morbidities increases and the impact of sepsis is expected to increase (Anonymous, [@B14]; Angus et al., [@B12]; Martin et al., [@B49]; Weycker et al., [@B87]).

Despite a large body of scientific literature concerning individual mechanisms involved in sepsis -- disordered endothelial activation (Aird, [@B3]; Ait-Oufella et al., [@B4]), organ dysfunction due to epithelial cell failure (Protti and Singer, [@B68]; Balestra et al., [@B17]), dysregulated inflammation and the associated complement, and coagulation networks (Rittirsch et al., [@B71]; Levi and van der Poll, [@B47]) -- the primary challenge lies in integrating a large body of data into a cohesive whole that can guide novel therapies. Effectively modulating, or controlling, the inflammatory response in sepsis, without adverse effects, has proven daunting. Currently no drug is approved by the U.S. Food and Drug Administration (FDA) for MODS. A previously approved drug, recombinant human activated protein C, failed to offer a benefit over standard of care on a FDA-mandated repeat Phase III clinical trial and was removed from the market (Angus, [@B11]; Mitka, [@B52]).

We suggest that the rational development of new therapies for sepsis and other acute inflammatory diseases requires characterizing the functional architecture and control points of multi-compartment inflammation. Specifically, we suggest that MODS could be thought of as arising from containment failure (i.e., failure to contain pathogens as well as failure to contain inflammation appropriately) driven by multi-scale "tipping points" that drive a forward feedback loop of inflammation → tissue damage/dysfunction → inflammation (An et al., [@B9]). We use the term "tipping point" to refer to a functional threshold beyond which a particular compartment/subsystem/system undergoes a phase transition from one range of dynamic behaviors to another. Implicit in this concept is that the internal feedback control processes of a particular compartment/subsystem act to maintain its behavior within a physiological functional range in response to perturbation, but that eventually the persistence and magnitude of the perturbation can lead to control failure. This control feature leads to a shift in the behavioral domain of the subsystem that can in turn lead to disorders in associated compartments/subsystems. This conceptual architecture has the potential to allow: (1) identification of intra-compartment-specific metrics that can be used to determine how close that compartment is to its "tipping point;" (2) identification of inter-compartmental control structures and their associated metrics for efficacy of control; and (3) propose both intra- and inter-compartmental control points that can be targeted for therapeutic intervention.

Studies from our groups, which coalesced under the U.S. National Institute of Health Computational Biology Program[^1^](#fn1){ref-type="fn"} and the Society for Complexity in Acute Illness[^2^](#fn2){ref-type="fn"}, have led us to hypothesize that these multi-scale inflammatory "tipping points," subsequent containment failure, and forward feedback to further propagate inflammation are either centrally controlled by neural circuits, or that neural circuits are activated once inflammation is induced in the brain during sepsis. We hypothesize that the structural/functional (parenchymal) cells of a given organ, once stressed or injured in a process that accompanies the degradation of organ physiology, release damage-associated molecular patterns (DAMPs) that in turn induce resident inflammatory (non-parenchymal) cells to produce classical pro-inflammatory cytokines, which in turn cause further release of DAMPs. Thus, inflammation would be controlled locally until the threshold for local control is exceeded. Co-incident with the peripheral inflammation, the brain "maps" the peripheral inflammation through its own expression of inflammatory cytokines. Brain inflammation would trigger processes aimed at vagal control of inflammation, to maintain physiologic homeostasis (Piepoli et al., [@B64]; Annane et al., [@B13]; Korach et al., [@B45]).This is a key point: parenchymal cells have no way of "sensing" directly that the organ in which they are contained is functioning in- or out-side its optimal operating parameters; only the brain can "sense" this dysfunction. Moreover, parenchymal cells exhibit dysfunction locally through the release of DAMPs that are "sensed" by inflammatory cells. In this scheme, "tipping points" could occur in two distinct locations -- a peripheral compartment in which the initial inflammation is manifest, and a "mirrored" representation of that compartment in the neural circuitry and tissue; both of these "tipping points" would affect -- and be affected by -- the physiologic function of a given organ. The implication of this hypothesis would be that centrally not only is there a loss of control but also dysfunctional control of other compartments, and that this dysfunction arises from the unique role of the brain as sensor and regulator of both organ function and inflammation.

We suggest that the use of data-driven and computational modeling, combined with experiments in relevant animals models of sepsis/MODS, is necessary to define and rationally modulate these "tipping points." Time-domain signal-processing analysis has correlated alterations (primarily decreases) in physiologic variability with morbidity and mortality in critically ill patients (Pomeranz et al., [@B65]; Anonymous, [@B15]; Godin et al., [@B40]; Korach et al., [@B45]; Barnaby et al., [@B18]; Pontet et al., [@B66]; Kleiger et al., [@B44]; Chen and Kuo, [@B25]; Ahmad et al., [@B2]; Fairchild et al., [@B35]). To unify these diverse observations, we hypothesize that the progress of tissue-level failure toward MODS is accompanied by defined inflammatory networks in different organs, is controlled by inflammation "maps" in the brain, and manifests as decreased physiologic variability (Figure [1](#F1){ref-type="fig"}A).

![**Conceptual models of organization. (A)** Inter-compartmental communication. Immune cells provoke activation of hormonal responses and neural controls, systemically manifested in alterations in cardiac activity. The interconnected nature of the regulatory interactions among compartments leads to the emergence of complex systemic responses. **(B)** Intra-compartment dynamics. At the cellular level, LPS is recognized by TLR4, activating the NF-κB signaling, leading to release of pro-inflammatory cytokines which turn on the anti-inflammatory machinery eventually leading to release of hormones driving sympathetic/parasympathetic imbalance altering heart beat patterns leading to diminished heart rate variability. Each individual compartment is characterized by its own, embedded, feedback regulatory structures. **(C)** Basic compartments of a physiologic system: Plant, Controlled Variables, and Controller. The plant is the coupled cardio-respiratory system functioning as single physiologic system serving gas exchange. In this system, blood gases and flow (e.g., vascular resistance, heart rate) are the controlled variables in delivering oxygen to various tissues. The controller generates rhythmic respiratory sympathetic and parasympathetic activities. Pink highlight, these red arrows relate to variables in the red box (1) Efference copy and (2) Mechano-receptors \[pulmonary stretch, muscle- and joint-, and baro-receptors\] which provide input to controller regarding plant performance on a breath-by-breath or beat-by-beat basis for a given motor signal (large black arrow). Yellow highlight: these arrows relate to how the controlled variables and the mechano-receptor afferents are modulated by the controller and in the presence of cytokines. The yellow and pink highlight areas relate to the nTS and dl pons, respectively. In the dl pons, we hypothesize that mechano-receptor afferent project to the dl pons (via the nTS) and interact with an Efference Copy produced by the controller. Efference Copy is defined as a copy of the motor signal delivered to the plant. Differences between these dl pontine inputs (e.g., the magnitude and strength of the muscle contraction, the lung inflation, etc) are compared to the generated motor signal. Loss of variability in the activity pattern of the plant can result from a failure of the controller to adapt to disparities between sensory input and Efference Copy. In the nTS, cytokines are expressed during ALI and, we expect sepsis, and may affect how afferent input is relayed to the controller. We propose a gating mechanism; one in which afferent inputs are depolarized and neural transmission efficacy is diminished.](fphys-03-00222-g001){#F1}

We have previously suggested a computational modeling approach to the dilemma of MODS that represents a conceptual departure from the current view of acute inflammation and MODS, and offers a new paradigm of MODS pathogenesis based on multifaceted, multi-compartment, and multi-scale inflammatory processes (An et al., [@B9]). This approach is based on the following premises:

-   The recognition -- suggested, driven, and linked by computational modeling -- that the inflammatory response is both compartmentalized and tightly coupled with physiological processes.

-   Given this architecture, that at a certain level of perturbation the reinforcing feedback loop of inflammation → damage/dysfunction → inflammation leads to failure of intra-compartment control. Such failure manifests as the crossing of compartment-specific "tipping points" that have "all-or-none" systemic and physiologic consequences (An et al., [@B9]).

-   That the control structure for integrating inflammation and physiology is based on neural circuits, and thus disordered and failing control of effectively contained inflammation is manifest as altered physiological variability (Namas et al., [@B60]).

-   Finally, that therapies should be targeted based on this structure and dynamic behavior.

Below, we discuss each of these points and suggest how they connect to drive a novel view of MODS.

The Inflammatory Response has a Compartmental Architecture
==========================================================

Inflammation is a prototypical complex system, with multi-feedback interactions among its components, robustness to perturbation coupled with the potential for severe failure at key nodes, and system-level properties difficult to intuit from reductionist analysis (Csete and Doyle, [@B31]; Vodovotz and An, [@B82]). We assert that these properties have led to the ineffectiveness of mediator-targeting systemic therapies. As a result, the clinical approach to MODS is focused on providing supportive care of specific points of end-organ failure (e.g., fluids and drugs to alleviate hypotension, ventilation to support failing lungs, etc.). Unfortunately, these interventions often have unintended "ripple effects" that propagate the disordered systemic inflammatory response to the overall detriment of the patient (Ferguson et al., [@B36]; Sakr et al., [@B73]; Cotton et al., [@B30]). Therefore, a disconnect exists between the clinical needs of supporting physiology-level organ function and the need to control the dynamics of the generative cellular-molecular processes that eventually determine that function. This gulf between the cellular-molecular biology of inflammation and organ physiology seen in MODS is precisely the multi-scale barrier that must be traversed to provide a rational basis for potential therapies for MODS.

We view the inflammatory response as compartmentalized both structurally and across multiple scales of organization (Boujoukos et al., [@B20]; Schein et al., [@B79]; Molina et al., [@B53]; Cavaillon and Annane, [@B24]). Why focus on compartments, when inflammation in sepsis manifests systemically? Despite the attractiveness of purely systemic therapy, the ineffectiveness of such interventions has been demonstrated in multiple studies in animal models of sepsis in which suppressing systemic inflammation resulted in immunosuppression and elevated morbidity and mortality due to overwhelming infection (Remick et al., [@B69]; Natanson, [@B61]). Similarly, an insufficient systemic inflammatory response is associated with elevated morbidity and mortality even in nominally sterile trauma/hemorrhage in both humans and swine (Namas et al., [@B58]). Thus, systemic-level interventions may lead to inappropriate damping of a necessary inflammatory response in those tissues and compartments that have not approached their "tipping point." We have begun to refine the dynamic relationships between inflammatory compartments to develop a roadmap toward the translational engineering of therapeutic interventions. We employ progressive use of traditional *in vivo* experiments and platforms, augmented by computational models to explore, explain, and bridge the fundamental aspects of multi-compartment inflammation.

The Architecture of Inflammation Leads to "Tipping Points" of Local Control Failure that Can Propagate to Systemic Failure
==========================================================================================================================

A central aspect of our interdisciplinary approach to deciphering the inflammatory response involves augmenting laboratory studies with computational models that can integrate, suggest, explain, and potentially predict biological knowledge and data. These computational models include both traditional mathematical models based on ordinary differential equations, as well as agent-based and rules-based models (Vodovotz et al., [@B84], [@B86], [@B85]; An et al., [@B7], [@B8]; Foteinou et al., [@B38]; Vodovotz and An, [@B82]; Mi et al., [@B51]; Namas et al., [@B60]). We initially discerned inflammatory "tipping points" using a multi-scale, multi-tissue, and multi-organ agent-based model (ABM) of the gut-lung axis of systemic inflammation (An, [@B5]). In this ABM, both organs are represented by spatially distinct, aggregated populations of epithelial and endothelial cells that interact with circulating inflammatory cells and mediators. Simulations of gut ischemia demonstrated a clear gut ischemia threshold, or "tipping point," beyond which MODS could be discerned: first ARDS, then systemic hypoxia, and ultimately *in silico* "death" (An, [@B5]). Simulation of ventilatory support allowed the system to tolerate more severe gut ischemia, but the "tipping point" persisted. Despite the abstraction of this ABM, it did provide early evidence of the role of compartmental inflammation on the generation of inflammatory "tipping points" and subsequent MODS, and suggested that interventions for sepsis might need to be targeted at the compartment level rather than systemically, or as an adjunct to systemic therapy.

In a similar vein, we created a two-compartment mathematical model of porcine endotoxemia (Nieman et al., [@B62]), based on an existing mathematical model of mouse endotoxemia (Chow et al., [@B28]; Lagoa et al., [@B46]; Prince et al., [@B67]; Torres et al., [@B80]). This previous single-compartment mathematical model of inflammation was capable of making qualitative and quantitative predictions with regard to endotoxin-induced inflammation and blood pressure in genetically identical mice (Chow et al., [@B28]; Lagoa et al., [@B46]; Prince et al., [@B67]; Torres et al., [@B80]). Without compartmentalization, we realized that key meta-behaviors of inflammation were absent, and thus multi-compartment models would be necessary to address the role of inflammatory "tipping." As in the gut/lung ABM described above, this equation-based model was extended to support clinical interventions such as a fluid resuscitation and mechanical ventilation (Nieman et al., [@B62]). Importantly, this model was capable of addressing individual variations in the porcine inflammatory and pathophysiologic response to endotoxin, including correlation with clinically useful indices such as the Oxygen Index (Nieman et al., [@B62]).

To define inflammatory networks that drive compartment-specific "tipping points," we have applied Dynamic Network Analysis (DyNA) algorithm (Mi et al., [@B50]), with a more recently developed Dynamic Bayesian Network (DyBN) algorithm (adapted from; Grzegorczyk and Husmeier, [@B41]). We utilized the DyBN method to examine the connectivity of inflammation in multiple organs in endotoxemic mice. These studies suggested a high degree of connectivity as well as feed-forward behavior for multiple chemokines, as well as the presence of indirect positive feedback loops, all of which appeared to induce the cytokine IL-6 (a biomarker of dysregulated inflammation in multiple contexts; Abraham and Singer, [@B1]; Namas et al., [@B59]).Based on these studies, we suggest that the compartment-specific response to inflammatory stimuli initially remains within a given compartment, helping to coordinate responses appropriate to a given stimulus. However, when the magnitude or duration of an inflammatory stimulus exceeds certain (likely genetically encoded) thresholds, the response spills over into other compartments. This process could occur via both the systemic and lymphatic circulation, leading to progressive organ dysfunction. We hypothesize that this dysfunction, in turn, further aggravates inflammation.

As noted above, one of our goals is to create multi-scale, multi-compartment computational models of inflammation, and (patho) physiology applicable across species, to transcend the barrier between pre-clinical and clinical studies (An et al., [@B6]). Accordingly, to facilitate comparison to computational modeling studies calibrated against data in mice (Chow et al., [@B28]), rats (Daun et al., [@B32]), and swine (Nieman et al., [@B62]), we have studied human systemic inflammation in the setting of endotoxemia.Even though species-specific thresholds of responsiveness to microbial product differ, each of the animal models share a common mammalian inflammatory response (Parker and Watkins, [@B63]). Endotoxemia triggers Toll-like receptor (TLR)4 signaling, and subsequent events propagate through a network of intimately connected and interacting compartments with an end result of either resolution of the inflammatory response, or a self-sustaining imbalance that, we hypothesize, drives inflammatory "tipping points" that manifest in organ dysfunction (Figure [1](#F1){ref-type="fig"}B).

In addition we performed data-driven analyses of high-dimensional leukocyte microarray data taken from human endotoxemia experiments (Calvano et al., [@B22]), identifying critical transcriptional responses to endotoxemia through a novel clustering approach (Yang et al., [@B89]). These responses were quantitatively linked through physicochemical modeling, producing an initial computational model of the transcriptional response to human endotoxemia (Foteinou et al., [@B37]).

To account for hormonal modulation of the inflammatory response (Figure [1](#F1){ref-type="fig"}B), pharmacokinetic/pharmacodynamic models linking the dynamics of epinephrine, cortisol, and endotoxemia were proposed (Foteinou et al., [@B37]). This approach provided fundamental information, so we could explore the impact of hormonal rhythmicity on host fitness, specifically Circadian rhythms (Coogan and Wyse, [@B29]). We developed a model to assess the impacts of circadian rhythmicity, as imposed by the suprachiasmatic nucleus (SCN) through circadian hormones, on the response to endotoxemia (Scheff et al., [@B75]). This model predicted a differential response to identical inflammatory inputs depending on the circadian phase, thus illustrating the importance in circadian rhythmicity in determining the response to endotoxemia.

Hormonal rhythmicity at time scales faster than circadian, called ultradian rhythms, are also increasingly being seen as partaking in important physiological functions (Desvergne and Heligon, [@B33]; Lightman and Conway-Campbell, [@B48]). Prominent among the implications of pulsatile secretion of cortisol is the potential role of these ultradian rhythms in regulating the appropriate homeostatic expression of glucocorticoid-responsive genes, including components of the peripheral circadian clock and inflammatory mediators. To investigate the impacts of ultradian rhythms further, we developed a model linking the ultradian production of cortisol in the hypothalamic-pituitary-adrenal (HPA) axis with its downstream effects, which showed the importance of rhythmic hormone patterns in signal transduction (Scheff et al., [@B78]). This work was extended to consider the same system in the stress response. One of our key findings was that the homeostatic amplitude of ultradian rhythms was predictive of the responsiveness of the HPA axis to stress (Scheff et al., [@B76]). This is an example of how characteristics embedded in physiologic rhythms can contain information about the state of a biological system. However, analysis at the level of heart rate variability (HRV) allows for much more significant translational applications through the potential to incorporate hormonal rhythms into single clinically accessible metric.

Inflammation, Breathing Pattern Variability and Biologically Variable Ventilation
=================================================================================

A central hypothesis underlying our work involves the cross-regulation of inflammation and physiology via neural control mechanisms. The basic elements of a physiologic system defined in engineering terms are the plant, controller, and sensor (Figure [1](#F1){ref-type="fig"}C). Generally, the plant is the end organ whose function is regulated to maintain controlled variables; the controller, a neural network modulating the plant; and the sensor, specialized cells monitoring levels of the controlled variables. Here (Figure [1](#F1){ref-type="fig"}C), the plant is the cardio-pulmonary system; the controller, the coupled cardio-respiratory central pattern generator (CPG; for details see; Baekey et al., [@B16]; Molkov et al., [@B54], [@B55]); and the controlled variables, blood gases, and flow for gas exchange.

Fundamental questions, which we are beginning to address, are: (1) How does cardio-respiratory control system "sense" peripheral dysfunction? (2) How does central expression of cytokines affect the control of a peripheral compartment and neural function itself? and (3) How are compartments organized in the brainstem? To sense dysfunction, we propose an interaction between efference copy and sensory input \[Figure [1](#F1){ref-type="fig"}C (1 and 2, in red highlight)\]. Efference copy is the expected effect, specifically, a "copy" of the motor output produced by the controller. This is compared to the sensory input, which is the effective output. Central expression of cytokines could modulate the controller within this functional loop (Figure [1](#F1){ref-type="fig"}C2, in yellow highlight) and by directly affecting the function of neurons in the CPG (Figure [1](#F1){ref-type="fig"}C1, no highlight). Further, the time-dependent properties of the expression of cytokines in this reduced control circuit are unknown; for instance, do cytokines become expressed sequentially or co-incidentally in different control nuclei? Further, cytokines definitely elicit "sickness" behavior, which will affect the output of automatic nuclei. Finally, cytokines evoke various second-messenger systems from glia and neurons and many of these second-messengers, including nitric oxide, act extracellularly. Control of other compartments may be elicited through spread of cytokines themselves, or of their second-order messengers.

As a dynamic controller, the respiratory CPG is capable of producing a wide repertoire of "output patterns" and a particular output pattern depends on peripheral and central inputs but also on prior experience and local internal milieu (Rybak et al., [@B72]). Without peripheral or central inputs, the respiratory CPG provides an output that is rhythmic and regular, i.e., characterized by low deterministic variability (Dhingra et al., [@B34]). Under normal conditions the intact cardio-respiratory system exhibits chaotic dynamics with deterministic variability (Sammon and Bruce, [@B74]). We theorize that alterations in the non-linear properties of cardio-respiratory variability associated with disease depend, at least partially, on cytokine-modulation of sensory feedback, and ponto-sensory interactions. In the presence of elevated levels of cytokines, the efficacy of sensory input is reduced, minimizing the non-linear deterministic properties of pattern variability (Figure [1](#F1){ref-type="fig"}C; Dhingra et al., [@B34]). Early models of breathing pattern during heart failure have demonstrated that increased gain and delayed feedback lead to sensor over-response and results in a waxing and waning pattern (Cherniack et al., [@B27]; Cherniack and Longobardo, [@B26]). In addition, pressure support ventilation (which effectively facilitates a gain of lung stretch receptors feedback) helps to maintain normal breathing pattern variability, which reduces when a patient is separated from ventilation (Wysocki et al., [@B88]).

We speculate that changes in deterministic variability in the cardio-respiratory patterns associated with systemic inflammation (Figure [2](#F2){ref-type="fig"}B3) are related to expression of cytokines in the nucleus *tractus solitarius* (nTS); which result from vagal input and which "maps" peripheral inflammation. We have preliminary evidence that acute lung injury results in specific expression of IL-1β in the commissural subnucleus in the nTS (Jacono et al., [@B43]; Figure [2](#F2){ref-type="fig"}A, serology in lower panel and Figure [2](#F2){ref-type="fig"}C, red fluorescent staining). This expression occurred in the absence of significant increases IL-1β, TNFα, and IL-6 in the plasma (Jacono et al., [@B43]). We have focused on the vagal afferent limb in controlling biologic pattern variability but this neural feedback lies in the context of its own control loop. The respiratory CPG, a major determinant of vagal efferent activity, modulates variability but may also regulate the expression of cytokines. Vagal efferent activity decreases peripheral levels of cytokines, acting as a negative feedback modulating the magnitude of the inflammatory response (Andersson and Tracey, [@B10]). However, the brainstem connectivity between the CPG network and the immunologic loop is unknown. In particular, it is unknown if the network that mediates biologic variability also modulates the magnitude of the inflammatory response. In defining this network, we speculate that this loop is affected by central expression of cytokines and, thus, has a role in determining the "tipping point" and systemic dysfunction.

![**Interleukin-1β expression is increased in the commissural subnucleus of the nTS in the setting of acute lung injury (ALI) and altered ventilatory pattern**. Bleomycin (three units) was instilled intratracheally causing ALI. Ventilatory pattern was measured and tissues were obtained 48 h later. **(A)** Histologic examination identified a significant increase in IL-1β in the commissural subnucleus of the nucleus *Tractus Solitarius* (nTS) in the dorsomedial medulla (shown). Abbreviations: AP, area postrema; CC, central canal; IV, fourth ventricle; X, dorsal motor nucleus of the vagus; XII, hypoglossal motor nucleus; white dashed line, solitary tract. **(B)** Compares ventilatory patterns of sham (blue) and ALI (red) rats at baseline and 48 h. After ALI: (1) Increased respiratory rate (significant decrease in cycle duration, TTOT), (2) Increased coefficient of variation (CV) of respiratory cycle length (CV of TTOT), and (3) Increased deterministic non-linear variability of the ventilatory pattern, as measured by a non-linear complexity index (NLCI, yellow highlight) computed using surrogate data analysis. **(C)** Fluorescent staining: IL-1β co-localized with nTS neurons (white arrows) identified using antibodies against the neuronal specific nuclear protein NeuN. (Adapted from; Wysocki et al., [@B88]).](fphys-03-00222-g002){#F2}

Further, improved understanding of the feedback loops involved in the neural control of inflammation will serve to identify novel targets for modulation of the immune response. For example, imposing rhythmic vagal afferent activity by mechanical ventilation may impact the neural and peripheral immune responses. Thus, one potential benefit of biologically variable ventilation is that it imposes a sensory input related to lung inflation that artificially replicates a variable "normal" signal. This may predispose the CPG to produce "normal" pattern that, perhaps, reduces inflammation. If biologic variability of rhythmic patterns decreases the cytokine concentration as compared to the "autonomous regime" then cardio-respiratory coupling and the variability in the bursting pattern of its activity, may prevent MODS and the inflammatory response from reaching its "tipping point."

Impaired Physiology Manifests as Altered and Often Reduced Physiologic Variability
==================================================================================

Variability is a property of the biological systems we have studied, that in and of itself is neither good nor bad, but may reflect a "state" of the system that is adaptable and responsive (within boundaries). HRV is diminished in various inflammatory conditions, including experimental human endotoxemia. Recent studies have investigated HRV as a predictive metric in trauma patients (Morris et al., [@B57]; Cancio et al., [@B23]; Riordan et al., [@B70]; Batchinsky et al., [@B19]) and sepsis (Ahmad et al., [@B2]; Moorman et al., [@B56]). Although correlations of HRV with disease state have produced many important insights, the physiological processes linking inflammation with systemic changes are not well defined, motivating the development of mathematical models linking inflammation, and HRV (Buchman, [@B21]; Foteinou et al., [@B39]; Scheff et al., [@B77]; Namas et al., [@B60]). We linked multilevel dynamics of the molecular and cellular patterns occurring in human endotoxemia to cardiac function through a model that outputs discrete heart beats as modulated by physiological rhythms, which can then be post-processed to assess HR and HRV (Scheff et al., [@B77]). Action potentials at the sinoatrial (SA) node of the heart initiate the contraction of cardiac tissue, producing rhythmic heart beats. Sympathetic and parasympathetic nerves converging at the SA node result in fluctuating levels of autonomic neurotransmitters which modulate the firing pattern of SA node cells. Variability in the firing of the SA node, and thus variability in the beating of the heart, is regulated by autonomic output. Thus, we proposed a model of autonomic activity at the SA node, influenced by the inflammatory mediators in our model of human endotoxemia, to modulate the HRV (Scheff et al., [@B77]). Our discrete modeling of heart beats allowed the calculation of HRV metrics used in the clinical setting. The diversity of data supporting this modeling work at transcriptional, hormonal, and systemic levels was matched by appropriate computational modeling techniques to allow for the assessment of autonomic dysfunction, manifested in altered HR rhythmicity, in human endotoxemia. We have demonstrated that stress induces alterations in the homeostatic dynamics of the feedback structures such that some level of perturbation permanently disrupts these regulatory structures; i.e., "tipping points." Progressive crossing of these "tipping points" would lead to cascading systems failure and the clinical syndrome of MODS/sepsis.

Conclusions, Future Developments, and Perspectives
==================================================

We suggest that our evolving mathematical models will help identify and predict potential bioactive interventions, and validate those predictions in further experiments in rodents, swine, and, ultimately, in clinical trials based on our *in silico* studies. The multi-compartment/multi-scale computational models could be used to test interventions targeted at effector organs, such as ventilation strategies aimed at manipulating the lung. Importantly, despite their limitations of abstraction of relevant biological interactions, mechanistic mathematical models have the potential to allow us to bridge the gap from rodent studies to large-animal studies and eventually to clinical studies (Vodovotz et al., [@B83]; An et al., [@B6]). Trans-species and trans-compartment mechanistic and data-driven modeling will also allow us to integrate those inflammatory networks that help drive "tipping point" behavior.
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